We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current GSK market cap is 69.12B. The company's latest EPS is GBP 2.3778 and P/E is 5.49.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 8.15B | 8.05B | 7.36B | 7.88B | 8.01B |
| Operating Income | 1.95B | 572M | 1.49B | 1.65B | 188M |
| Net Income | 1.46B | 350M | 1.05B | 1.17B | -58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 33.75B | 34.1B | 34.11B | 34.91B | 30.33B |
| Operating Income | 6.24B | 5.08B | 6.67B | 8.43B | 7.35B |
| Net Income | 4.65B | 5.75B | 4.39B | 14.96B | 4.93B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 60.86B | 59.01B | 58.51B | 58.07B | 58.05B |
| Total Liabilities | 48.24B | 46.21B | 45.28B | 44.3B | 44.6B |
| Total Equity | 12.62B | 12.8B | 13.23B | 13.77B | 13.45B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 79.69B | 80.43B | 79.1B | 60.15B | 59.01B |
| Total Liabilities | 61.34B | 59.62B | 57.76B | 50.05B | 46.21B |
| Total Equity | 18.36B | 20.81B | 21.34B | 10.1B | 12.8B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 3.57B | 6.77B | 958M | 2.07B | 4.23B |
| Investing | -1.86B | -1.6B | -149M | 621M | -110M |
| Financing | -2.05B | -5.64B | -1.06B | -2.64B | -3.88B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 8.02B | 8.44B | 7.95B | 7.4B | 6.77B |
| Investing | -5.35B | 2.16B | -1.78B | -8.77B | -1.6B |
| Financing | -1.84B | -10.13B | -7.59B | 823M | -5.64B |
| Market Cap | 69.12B |
| Price to Earnings Ratio | 5.49 |
| Price to Sales Ratio | 0.89 |
| Price to Cash Ratio | 9.22 |
| Price to Book Ratio | 2.12 |
| Dividend Yield | 4.67% |
| Shares Outstanding | 2.07B |
| Average Volume (1 week) | 7.09M |
| Average Volume (1 Month) | 7.09M |
| 52 Week Change | -3.05% |
| 52 Week High | 45.925 |
| 52 Week Low | 32.98 |
| Spread (Intraday) | 0.35 (1.05%) |
| Company Name | GSK plc |
| Address |
79 new oxford street london WC1A 1DG |
| Website | https://www.gsk.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
